Patents Assigned to Deprenyl Animal Health, Inc.
  • Method for survival curve shifting in dogs
    Patent number: 5565495
    Abstract: Selegiline, or a pharmaceutically acceptable salt form of selegiline, is administered to mammals commencing at a point in time at which at least 50% of the mammal's life span is completed, with the administration continuing on a periodic but regular basis over the remaining life span of the mammal. The treatment, which shifts the survival curve, is especially useful for dogs.
    Type: Grant
    Filed: September 6, 1994
    Date of Patent: October 15, 1996
    Assignee: Deprenyl Animal Health, Inc.
    Inventors: David R. Stevens, William W. Ruehl
  • Treating hearing loss with deprenyl
    Patent number: 5561163
    Abstract: Selegiline and pharmaceutically acceptable analog forms thereof are used as treatments for hearing loss in mammals, especially dogs.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: October 1, 1996
    Assignee: Deprenyl Animal Health, Inc.
    Inventors: William W. Ruehl, David R. Stevens
  • L-deprenyl for treating immune system dysfunction and compositions for same
    Patent number: 5387615
    Abstract: Use of L-deprenyl for treatment of immune system dysfunction for mammals.
    Type: Grant
    Filed: August 27, 1993
    Date of Patent: February 7, 1995
    Assignee: Deprenyl Animal Health, Inc.
    Inventors: Norton W. Milgram, David R. Stevens, Gwendolyn O. Ivy
  • L-deprenyl for treating immune system dysfunction
    Patent number: 5276057
    Abstract: Use of l-deprenyl for treatment of immune system dysfunction for mammals.
    Type: Grant
    Filed: November 12, 1992
    Date of Patent: January 4, 1994
    Assignee: Deprenyl Animal Health, Inc.
    Inventors: Norton W. Milgram, David R. Stevens, Gwendolyn O. Ivy
  • Use of 1-deprenyl for retention of specific physiological functions
    Patent number: 5225446
    Abstract: 1-Deprenyl and pharmaceutically acceptable analog forms thereof are used at specific dosage levels and frequency of dosage to slow the normal age dependent deterioration of renal function, to provide increased exploratory behavior level of activity at any given age and in order to retard age deterioration of cognitive abilities, especially spatial learning ability. The treatment can be especially useful for mammals, for examples pets such as dogs and cats.
    Type: Grant
    Filed: July 14, 1992
    Date of Patent: July 6, 1993
    Assignee: Deprenyl Animal Health, Inc.
    Inventor: Norton W. Milgram
  • Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)
    Patent number: 5192808
    Abstract: A method of treating Cushing's Disease comprising treating mammals, and especially humans, dogs, horses or ponies with from 0.01 to about 4.0 mg/kg of body weight of L-Deprenyl, preferably daily, to achieve and maintain remission.
    Type: Grant
    Filed: March 27, 1992
    Date of Patent: March 9, 1993
    Assignee: Deprenyl Animal Health, Inc.
    Inventors: William W. Ruehl, David S. Bruyette, David Stevens
  • Use of L-deprenyl for retention of specific physiological functions
    Patent number: 5151449
    Abstract: L-Deprenyl and pharmaceutically acceptable analog forms thereof are used at specific dosage levels and frequency of dosage to slow the normal age dependent deterioration of renal function, to provide increased exploratory behavior level of activity at any given age and in order to retard age deterioration of cognitive abilities, especially spatial learning ability. The treatment can be especially useful for mammals, for examples pets such as dogs and cats.
    Type: Grant
    Filed: August 31, 1990
    Date of Patent: September 29, 1992
    Assignee: Deprenyl Animal Health, Inc.
    Inventor: Norton W. Milgram